Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Respiratory Medicine · مجلد 14 (3) · 233-255
Research outputs
مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.
278 مُخرَج
The Lancet Respiratory Medicine · مجلد 14 (3) · 233-255
RSC Advances · مجلد 16 (6) · 5561-5577
The current study focuses on the development of pH-sensitive hydrogels for the controlled release of mesalamine at a specific pH. A free radical polymerization technique was used, and the formulated hydrogels were characterized by Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis, scanning electron microscopy, swelling and drug release studies. FTIR confirmed the successful formation of a polymeric network with efficient incorporation of the drug. TGA revealed that the hydrogel demonstrated significantly improved thermal stability compared to the unmodified polymer, with SEM images showing a rough surface with a notable porous structure. Swelling and drug release behaviors were assessed at 37 °C in buffer solutions simulating gastric (pH 1.2) and intestinal (pH 7.4) conditions. The results demonstrated significantly higher swelling ratios and drug release rates at pH 7.4, indicating pH-responsive characteristics of the formulation, favoring enhanced drug release in the intestinal conditions. Increasing the concentrations of hyaluronic acid and acrylic acid led to enhanced porosity, improved swelling behavior, increased drug loading capacity, faster release rates, and a higher gel fraction, while simultaneously reducing the sol fraction. These observations suggested that the developed pH-sensitive hydrogel holds considerable potential as an effective carrier for pH-responsive, site-specific drug delivery systems. This study highlights the significant advancements in the design of hydrogels with tailored properties for controlled drug release, offering new opportunities for precision medicine.
PLoS ONE · مجلد 21 (2) · e0341183-e0341183
BACKGROUND: Polypharmacy and potential drug-drug interactions (pDDIs) are major challenges in the management of elderly patients with multiple comorbidities, often leading to adverse drug events and increased healthcare burden. AIM: This study aimed to determine the prevalence and patterns of polypharmacy and pDDIs among elderly patients attending Yenepoya Medical College and Hospital, Mangalore, India. METHODS: A cross-sectional study was conducted from January to June 2023 among 310 elderly patients (aged ≥60 years) selected through simple random sampling from both in-patient and out-patient departments. Polypharmacy was defined as the concurrent use of ≥5 medications, and excessive polypharmacy as ≥9 medications. Drug interaction screening was performed using UpToDate and Medscape interaction checker tools. Statistical analyses included descriptive statistics, t-tests, chi-square tests, and regression analysis, with significance set at p < 0.05. RESULTS: The prevalence of polypharmacy was slightly higher in females (53.84%) than males (51.94%), with the highest rates observed in the 70-79 age group (48.88%). Most patients experienced moderate (50%) drug interactions. A significant gender difference was observed in the number of drugs prescribed at treatment (p = 0.0032), but not at discharge. Regression analysis identified gender (p = 0.018) and inpatient status (p < 0.001) as significant predictors of polypharmacy, while age was not (p = 0.719). CONCLUSION: This study reveals a high prevalence of polypharmacy among elderly patients attending Yenepoya Medical College and Hospital. Polypharmacy was found to be more prevalent among female patients, older age groups, and in inpatient wards. The distribution of drug interactions revealed a pervasive nature across various degrees, with moderate interactions being the most common. Future research should use larger samples, and diverse populations to better understand polypharmacy, drug interactions, and outcomes.
Scientific Reports · مجلد 16 (1)
Long-term, flexible therapy strategies are needed for chronic diseases like cardiovascular ailments, diabetes, and chronic kidney disease and they have to deal with patient heterogeneity, changing physiological states and privacy constraints. This research suggests a framework for privacy-preserving and personalized artificial intelligence that combines Federated Learning (FL), a Res-HyperTransformerNet deep prediction model, Personalized Multi-Agent Reinforcement Learning (PMARL) and Explainable Artificial Intelligence (XAI) for adaptive chronic disease management. The framework is structured with two main aims: (i) to create an accurate and privacy-aware predictive model for chronic disease risk using diverse data sources, and (ii) to permit adaptive, individual therapy optimization through multi-agent reinforcement learning. Federated learning is utilized to conduct the training of Res-HyperTransformerNet over distributed Internet of Medical Things (IoMT) nodes without the requirement of transferring raw patient data. The embeddings that are created from patient data are then passed on to a PMARL module, where several agents optimize therapy dimensions like medications, diet, physical activity, and mental health interventions independently. To make the clinical support more understandable, the SHAP-based explainability method is used for both predictive and decision-making parts. The framework is tested using two public datasets—the CDC Chronic Disease dataset and the UCI Chronic Kidney Disease Risk Factor dataset. The performance is measured by employing classification metrics (accuracy, precision, recall, F1-score, MCC) as well as reinforcement learning metrics (reward score, convergence steps, episode return) and federated system metrics (communication overhead, convergence rounds, and training time). The experiments indicate that the proposed framework demonstrated improved performance in terms of predictive accuracy and policy convergence speed compared to the baseline deep learning and reinforcement learning models, and at the same time it is more cost-effective when it comes to communication in a federated setting. This means that the proposed method suggests the potential of being a reproducible and open AI framework for adaptive chronic disease therapy management. The combination of ResNet and Transformer blocks, i.e., Federated Res-HyperTransformerNet, achieved strong performance in both datasets, namely CDC Chronic Disease (Dataset 1) and UCI CKD Risk Factor (Dataset 2). The obtained accuracy for Dataset 1 was 98.61% and for Dataset 2, it was 97.75%, under the conducted experimental settings.
Journal of Drug Delivery Science and Technology · مجلد 119 · 108141-108141
Journal of Reliable and Secure Computing · مجلد 2 (1) · 1-26
The rapid proliferation of smart home IoT devices has introduced unprecedented cybersecurity vulnerabilities, necessitating scalable and privacy-preserving intrusion detection systems (IDS). Federated Learning (FL) offers a promising decentralized approach by training models locally without sharing raw data, but it remains susceptible to poisoning attacks and relies on a vulnerable central aggregator. This paper presents a novel blockchain-enhanced FL framework tailored for smart home IDS, integrating multiple consensus mechanisms—Proof-of-Stake (PoS), Practical Byzantine Fault Tolerance (PBFT), and Proof-of-Authority (PoA)—for the first time in this context. Our approach uniquely combines differential privacy (DP) and secure aggregation (SA) within a blockchain-managed workflow to mitigate gradient inversion and membership inference attacks while ensuring tamper-resistant, decentralized trust. Experimental evaluation using the N-BaIoT dataset demonstrates that the proposed system achieves up to 88.3% detection accuracy with manageable latency (~200 ms/round) and formal privacy guarantees ($\varepsilon$=1.0 DP). The framework introduces 52.8% system overhead compared to vanilla FL—a reasonable trade-off for enhanced security and privacy. This work establishes a robust, transparent, and scalable security infrastructure for smart homes, effectively addressing the limitations of both centralized and conventional FL-based IDS.
Journal of Chromatography B · مجلد 1272 · 124927-124927
Scientific Reports · مجلد 16 (1) · 3179-3179
With growing urbanization, there are increasing demands on waste management systems that can be performed in an environmentally friendly way as well as efficiently. Current approaches to managing waste often have issues with efficiency, transparency, and engaging with the public. Blockchain technology has been identified as one potential solution to these problems because it offers several benefits including decentralization, security, and transparency. The selection of the best blockchain-based waste management (BBWM) system is very difficult due to the many different evaluation criteria that may conflict with each other. Therefore this research uses a multi-criteria decision making (MCDM) approach using CIMAS (Criteria Importance Assessment), for determining weights based upon subjective input, and LOPCOW (Logarithmic Percentage Change-Driven Objective Weighing), for determining weights based upon objective data within the MCDM framework. To rank alternatives effectively, an Alternative Ranking Order Method Accounting for Two-Step Normalization (AROMAN) technique is applied, ensuring a precise evaluation process. The use of T-Spherical Fuzzy Sets (T-SFS) captures all three (membership, non-membership, hesitation degree) and is used to address the variability that exists when making an expert judgment. Some of the key factors include; Technological Feasibility, Operational Costs, Scalability, Data Security, Regulatory Compliance, Environmental Impact. Based on the evaluation criteria, it appears that the Blockchain Enabled Waste Tracking System is the most appropriate alternative due to its high potential for Transparency, Regulatory Compliance and Fraud Prevention. In addition, this research will provide Policymakers, Urban Planners and Investors with a methodical way of making Data Driven Decisions on BBWM Investments.
RSC Advances · مجلد 16 (8) · 7132-7148
required higher concentrations (84.33% at 75% MBC). These results demonstrated that marine bacterial metabolites produce biocompatible Se-Cu BMNPs with potent antioxidant, anti-inflammatory, antimicrobial, and antibiofilm properties suitable for biomedical applications.
Scientific Reports · مجلد 16 (1)
The Eucalyptus globulus essential oil (EGEO) is widely recognized for its pharmacological relevance; however, comprehensive evaluation of its phytochemical composition and bioactivities remains limited. In this study, EGEO was extracted from fresh leaves via hydro-distillation and characterized using GC-MS, LCMS, FTIR, and UV-Visible spectroscopy. Qualitative screening confirmed the presence of key secondary metabolites, including triterpenoids, flavonoids, phenols, steroids. Quantitative analysis revealed high levels of total phenolics (65.12 ± 0.01 mg GAE/g) and flavonoids (57.75 ± 0.01 mg QE/g). The oil exhibited concentration-dependent antioxidant activity in the DPPH assay with an IC₅₀ value of 604.01 µl/mL, indicating potent radical-scavenging ability. Anti-inflammatory assessment through protein denaturation and human red blood cell (HRBC) membrane stabilization assays demonstrated moderate inhibitory and cytoprotective effects comparable to standard drugs. EGEO also showed strong antibacterial efficacy against Tannerella forsythia, Prevotella intermedia and Aggregatibacter with inhibition zones of 19-25 mm while showed notable antibiofilm activity against T. forsythia. Cytotoxic evaluation indicated selective action, showing minimal toxicity toward normal L929 fibroblasts and moderate inhibition of B16F10 melanoma cells. Overall, these findings suggest that Eucalyptus globulus essential oil is a rich source of bioactive phytoconstituents with potential therapeutic applications as a natural antioxidant, anti-inflammatory, antibacterial, antibiofilm, and anticancer agent.
Ain Shams Engineering Journal · مجلد 17 (5) · 104098-104098
The rapid growth of cities demands sophisticated decision support systems capable of simultaneously tackling social, economic, and environmental issues in urban planning. This research introduces a comprehensive decision-making framework that integrates machine learning to optimize urban infrastructure development. To improve the reliability of the analysis, recursive feature elimination paired with random forest (RF-RFE) is utilized to pinpoint the most critical factors, ensuring that the decision process emphasizes the features that matter most. To handle uncertainty and vagueness in expert evaluations, picture fuzzy sets are implemented, allowing a nuanced expression of hesitation, while the entropy method is employed to objectively determine the weights of social, economic, and environmental criteria, thereby reducing subjective influence. The evaluation based on the approach of relative utility and nonlinear standardization (ERUNS) is employed to rank urban planning alternatives, capturing the nonlinear interactions among criteria. This framework provides a comprehensive, data-driven decision support tool for urban planners and policymakers to address the intricate and dynamic challenges of modern urbanization.
Scientific Reports · مجلد 16 (1)
Neurodegenerative disorders such as Parkinson’s disease are closely associated with dysregulated activity of monoamine oxidase-B (MAO-B), which leads to dopamine depletion and oxidative stress. Despite the availability of numerous monoamine oxidase (MAO) inhibitors on the market, their irreversibility and associated side effects necessitate the development of more effective and reversible MAO-B inhibitors. In this study, a series of twenty-one indole-based derivatives (PSH1 - PSH21) , collectively designated as PSH , was synthesised and evaluated for inhibitory activity against MAO isoforms. Most synthesised compounds showed higher inhibitory activity toward MAO-B than MAO-A, indicating selectivity for MAO-B. Among the PSH derivatives, PSH18 exhibited the most potent MAO-B inhibitory activity (IC 50 = 0.95 ± 0.02 µM), followed by PSH6 ( IC 50 = 1.79 ± 0.40 µM) and PSH2 (IC 50 = 1.96 ± 0.08 µM). Compound PSH18 showed the highest selectivity index value of 42.11, followed by PSH6 (22.35) and PSH2 (20.41). Additionally, PSH18 was confirmed to be a competitive and reversible inhibitor of MAO-B with an inhibition constant value of 0.89 ± 0.035 µM. Notably, PSH18 exhibited good permeability across the blood–brain barrier in parallel artificial membrane permeability assay experiments, along with acceptable absorption, distribution, metabolism, excretion, and toxicity parameters predicted through in silico modelling, suggesting its potential as a central nervous system-targeted molecule. Molecular docking and a 200 ns molecular dynamics simulation demonstrated stable binding of the ligand to the MAO-B active-site pocket, driven by hydrophobic and π–π stacking interactions with key amino acid residues lining the aromatic cage. Moreover, the calculated binding energy indicated strong ligand–protein interactions. Overall, these results indicate that the PSH scaffold could serve as a promising lead structure for the development of potent and selective MAO-B inhibitors. These compounds may have therapeutic potential for the treatment of neurodegenerative diseases.
International Communications in Heat and Mass Transfer · مجلد 174 · 110904-110904
Egyptian Informatics Journal · مجلد 33 · 100915-100915
The increasing complexity and sophistication of cyber threats have heightened the need for robust security mechanisms throughout the Software Development Lifecycle (SDLC). Traditional security methods have proven insufficient in addressing evolving risks, prompting the exploration of advanced technologies such as Artificial Intelligence (AI). However, integrating AI into SDLC raises challenges related to human-AI collaboration, trust, and alignment. This paper aims to explore the synergistic collaboration between Human Agentic and AI agents to enhance the security of SDLC. By integrating human expertise with AI capabilities, the study investigates how this collaboration can address existing security gaps and improve threat detection, vulnerability management, and secure code development. A qualitative approach is employed, reviewing existing literature on Human-Agentic AI frameworks, AI-driven security models, and their application in SDLC security. We also propose a conceptual framework for Human Agentic-AI collaboration in SDLC security, encompassing AI’s role in automated threat detection, vulnerability scanning, and model optimization, alongside human agents’ roles in decision-making, risk evaluation, and response validation. The proposed framework demonstrates that combining human intuition with AI’s computational power significantly enhances the security posture of SDLC processes. AI’s ability to quickly process and analyze large datasets complements human agents’ contextual understanding, leading to more effective identification of vulnerabilities and proactive security measures. The collaboration results in improved threat mitigation strategies, faster response times, and more reliable secure code deployment. The integration of Human Agentic-AI collaboration offers promising potential in enhancing SDLC security. The synergistic approach bridges the limitations of traditional methods and AI systems, offering a more dynamic and adaptable security solution. Future research should focus on optimizing human-AI interfaces and addressing trust and transparency challenges to further strengthen SDLC security.
Journal of Drug Delivery Science and Technology · مجلد 119 · 108140-108140